Correction to Lancet Infect Dis 2025; published online July 14. https://doi.org/10.1016/S1473-3099(25)00344-5

Abstract

Schnoz A, Sprecher VP, Biendl S, et al. Efficacy and safety of moxidectin–albendazole combination therapy for Trichuris trichiura infections in school-aged children: a double-blind, randomised, controlled, superiority trial. Lancet Infect Dis 2025; published online July 14. https://doi.org/10.1016/S1473-3099(25)00344-5—In this Article the labels for arithmetic mean eggs per g have been clarified in table 2. The sentence structure to paragraph five of the Results has been updated to remove ambiguity, but no results have been changed; the arithmetic mean reduction rate for moxidectin–albendazole has been corrected to 91·1%; and some appendix page numbers have been updated throughout the text. These corrections have been made to the online version as of July 25, 2025, and will be made to the printed version.